Arcadia Biosciences Inc
F:17DN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Arcadia Biosciences Inc
F:17DN
|
US |
|
ICoP SpA SB
F:ZU2
|
IT |
|
McCoy Global Inc
F:773
|
CA |
|
S
|
Sadhna Broadcast Ltd
BSE:540821
|
IN |
|
Versamet Royalties Corp
NASDAQ:VMET
|
CA |
|
Z
|
Zinc of Ireland NL
F:39G
|
AU |
|
C
|
CPU Softwarehouse AG
SWB:CPU2
|
DE |
|
F
|
FAR Ltd
OTC:FARYF
|
AU |
|
Sure Ventures PLC
F:08F
|
UK |
|
A
|
Aimflex Bhd
KLSE:AIMFLEX
|
MY |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 17DN's stock price target?
Not Available
17DN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Arcadia Biosciences Inc?
Projected CAGR
62%
Over the last 12 years, the compound annual growth rate for Revenue has been -2%. The projected CAGR for the next 1 year is 62%.
What is the Gross Profit forecast for Arcadia Biosciences Inc?
Projected CAGR
35%
Over the last 12 years, the compound annual growth rate for Gross Profit has been -9%. The projected CAGR for the next 1 year is 35%.